EMERGENT BIOSOLUTI revenue for the last year amounted to 883.44 M CHF, the most of which — 418.69 M CHF — came from its highest performing source at the moment, Commercial Products. The greatest contribution to the revenue figure was made by United States — last year it brought EMERGENT BIOSOLUTI 511.22 M CHF, and the year before that — 822.54 M CHF.